Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
Bioceres closed fiscal 2026 with revenue from continuing operations of $238.3 million, down 18% year over year, with roughly half the decline tied to the substantially completed reconfiguration of its Seeds business and reduced HB4-related activity. Fourth-quarter operations inflected: revenue was broadly stable at $55.9 million, the net loss from continuing operations narrowed to $31.8 million from $54.4 million, and Adjusted EBITDA swung to positive $0.6 million on cost actions that cut FY26 SG&A by 24%.
Key figures
- Revenue
- 238300000
- Revenue Yoy
- -18%
- Sgna fy26
- 71200000
- Q4 revenue
- 55900000
- Total equity
- 64100000
- Q4 revenue yoy
- +1%
- Gross profit q4
- 12700000
- Gross margin fy26
- 34.8%
- Gross profit fy26
- 82900000
- Sgna reduction fy26
- 24%
- Weighted avg shares
- 63600000
- Adjusted ebitda fy25
- 28900000
- Adjusted ebitda fy26
- 25500000
- Cash and equivalents
- 11200000
- Secured notes current
- 118600000
- Crop nutrition revenue fy26
- 77000000
- Crop protection revenue fy26
- 123700000
- Equity attributable to owners
- 39100000
- Inventory obsolescence charge q4
- 4000000
- Seeds integrated products revenue fy26
- 37700000
AI analysis
Red flags7 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.